Beckman Coulter Life Sciences, a subsidiary of Beckman Coulter, operates within the manufacturing sector, specializing in test and measurement equipment for healthcare and biotechnology applications. Founded in 1935 and headquartered in the United States, the company employs between 5,001 and 10,000 individuals and reported significant revenue. Its published documents indicate a strong focus on advanced analytical techniques, particularly in the areas of analytical ultracentrifugation (AUC) and flow cytometry. The white paper on multiwavelength analytical ultracentrifugation highlights the technology's capability to analyze biopolymer interactions and quantify samples with distinct absorbance profiles, emphasizing its advantages over traditional methods. Additionally, the technical reports discuss the comparative benefits of spectral flow cytometry, showcasing the company's commitment to enhancing analytical precision and efficiency in biological research. Overall, Beckman Coulter Life Sciences is positioned as a key player in providing innovative solutions for molecular studies and healthcare diagnostics.